184 related articles for article (PubMed ID: 18372010)
1. Relationship between patient age and superficial transitional cell carcinoma characteristics.
Shi B; Zhang K; Zhang J; Chen J; Zhang N; Xu Z
Urology; 2008 Jun; 71(6):1186-90. PubMed ID: 18372010
[TBL] [Abstract][Full Text] [Related]
2. Clinical characteristics of bladder urothelial tumors in female patients.
Zhang NZ; Chen J; Wang HQ; Xu ZS
Menopause; 2010 Mar; 17(2):421-5. PubMed ID: 19713871
[TBL] [Abstract][Full Text] [Related]
3. [Clinical observations on bladder cancer--difference in clinical features with age].
Noguchi S; Kubota Y; Shuin T; Masuda M; Yao M; Miura T; Moriyama M; Sakuramoto T; Ishibashi Y; Misaki H
Hinyokika Kiyo; 1993 Dec; 39(12):1131-8. PubMed ID: 8285161
[TBL] [Abstract][Full Text] [Related]
4. [Bladder cancer in elderly patients].
Isaka S; Igarashi T; Akimoto S; Okano T; Shimazaki J; Matsuzaki O
Hinyokika Kiyo; 1984 Dec; 30(12):1793-9. PubMed ID: 6532207
[TBL] [Abstract][Full Text] [Related]
5. Differences in tumor characteristics and prognosis in newly diagnosed Ta, T1 urothelial carcinoma of bladder according to patient age.
Cho KS; Hwang TK; Kim BW; Yoon DK; Chang SG; Kim SJ; Park JY; Cheon J; Sung GT; Hong SJ;
Urology; 2009 Apr; 73(4):828-32, 832.e1. PubMed ID: 19195693
[TBL] [Abstract][Full Text] [Related]
6. Ta T1 low and intermediate transitional cell carcinoma of the bladder: recurrence rates and the timing of check cystoscopies within the first year.
Guney S; Guney N; Canogullari Z; Ergenekon E
Urol Int; 2008; 80(2):124-8. PubMed ID: 18362479
[TBL] [Abstract][Full Text] [Related]
7. Bladder conservation treatment in the elderly population: results and prognostic factors of muscle-invasive bladder cancer.
Tran E; Souhami L; Tanguay S; Rajan R
Am J Clin Oncol; 2009 Aug; 32(4):333-7. PubMed ID: 19381080
[TBL] [Abstract][Full Text] [Related]
8. [Transitional cell bladder carcinoma in patients younger than 40 years of age].
Madrid García FJ; Parra Muntaner L; Rivas Escudero JA; Sánchez Sánchez E; Monsalve Rodríguez M; Gómez Cisneros S; García Alonso J
Arch Esp Urol; 1998 Dec; 51(10):991-4. PubMed ID: 9951121
[TBL] [Abstract][Full Text] [Related]
9. Pattern of metastases in relation to characteristics of primary tumor and treatment in patients with disseminated urothelial carcinoma.
Sengeløv L; Kamby C; von der Maase H
J Urol; 1996 Jan; 155(1):111-4. PubMed ID: 7490804
[TBL] [Abstract][Full Text] [Related]
10. Pattern of recurrence changes in noninvasive bladder tumors observed during 2 decades.
Mariappan P; Smith G; Lamb AD; Grigor KM; Tolley DA
J Urol; 2007 Mar; 177(3):867-75; discussion 875. PubMed ID: 17296362
[TBL] [Abstract][Full Text] [Related]
11. Comparison of American Joint Committee on Cancer pathologic stage T3a versus T3b urothelial carcinoma: analysis of patient outcomes.
Boudreaux KJ; Chang SS; Lowrance WT; Rumohr JA; Barocas DA; Cookson MS; Smith JA; Clark PE
Cancer; 2009 Feb; 115(4):770-5. PubMed ID: 19152431
[TBL] [Abstract][Full Text] [Related]
12. Comparison of american joint committee on cancer pathological stage T2a versus T2b urothelial carcinoma: analysis of patient outcomes in organ confined bladder cancer.
Boudreaux KJ; Clark PE; Lowrance WT; Rumohr JA; Barocas DA; Cookson MS; Smith JA; Chang SS
J Urol; 2009 Feb; 181(2):540-5; discussion 546. PubMed ID: 19084855
[TBL] [Abstract][Full Text] [Related]
13. The risk factor for urethral recurrence after radical cystectomy in patients with transitional cell carcinoma of the bladder.
Cho KS; Seo JW; Park SJ; Lee YH; Choi YD; Cho NH; Yang SC; Hong SJ
Urol Int; 2009; 82(3):306-11. PubMed ID: 19440019
[TBL] [Abstract][Full Text] [Related]
14. The safety and efficacy of different doses of bacillus Calmette Guérin in superficial bladder transitional cell carcinoma.
Agrawal MS; Agrawal M; Bansal S; Agarwal M; Lavania P; Goyal J
Urology; 2007 Dec; 70(6):1075-8. PubMed ID: 18158020
[TBL] [Abstract][Full Text] [Related]
15. Clinical outcome of tumor recurrence for Ta, T1 non-muscle invasive bladder cancer from the data on registered bladder cancer patients in Japan: 1999-2001 report from the Japanese Urological Association.
Kikuchi E; Fujimoto H; Mizutani Y; Okajima E; Koga H; Hinotsu S; Shinohara N; Oya M; Miki T;
Int J Urol; 2009 Mar; 16(3):279-86. PubMed ID: 19207609
[TBL] [Abstract][Full Text] [Related]
16. Conservative management of low risk superficial bladder tumors.
Pruthi RS; Baldwin N; Bhalani V; Wallen EM
J Urol; 2008 Jan; 179(1):87-90; discussion 90. PubMed ID: 17997444
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of bacillus Calmette-Guérin in the treatment of superficial bladder cancer: the impact of previous intravesical treatment.
Okamura T; Akita H; Imura M; Kaneko T; Mizuno K; Tozawa K; Kohri K
Int J Urol; 2008 Oct; 15(11):976-80. PubMed ID: 18721199
[TBL] [Abstract][Full Text] [Related]
18. Transitional cell carcinoma of the urinary bladder: a clinicopathological study.
Matalka I; Bani-Hani K; Shotar A; Bani Hani O; Bani-Hani I
Singapore Med J; 2008 Oct; 49(10):790-4. PubMed ID: 18946612
[TBL] [Abstract][Full Text] [Related]
19. Significance of muscularis mucosae in metastasis involvement of urinary bladder transitional cell carcinoma.
Chaimuangraj S; Dissaranan C; Leenanupunth C; Prathombutr P; Chalermsanyakorn P
J Med Assoc Thai; 2006 Sep; 89(9):1447-53. PubMed ID: 17100383
[TBL] [Abstract][Full Text] [Related]
20. Association between age and clinical characteristics of renal cell carcinoma in adult patients.
Jun C; Zhishun X; Xianzhou J; Qiang F; Jin W
Int J Urol; 2006 May; 13(5):515-9. PubMed ID: 16771718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
